C07K 14/7158
For chemokines
Official title: {for chemokines}
C07K14/7158 (For chemokines) appears on 286 US grants and 525 published applications in this corpus.
Search patents in C07K- Granted patents
- 286
- Published applications
- 525
- Assignees
- 292
- Inventors
- 903
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 3 | 0 |
| 1999 | 7 | 0 |
| 2000 | 9 | 0 |
| 2001 | 10 | 3 |
| 2002 | 11 | 42 |
| 2003 | 6 | 41 |
| 2004 | 25 | 25 |
| 2005 | 9 | 20 |
| 2006 | 14 | 27 |
| 2007 | 13 | 8 |
| 2008 | 10 | 14 |
| 2009 | 9 | 16 |
| 2010 | 7 | 9 |
| 2011 | 5 | 14 |
| 2012 | 5 | 11 |
| 2013 | 3 | 10 |
| 2014 | 7 | 16 |
| 2015 | 12 | 10 |
| 2016 | 7 | 13 |
| 2017 | 9 | 19 |
| 2018 | 10 | 22 |
| 2019 | 15 | 21 |
| 2020 | 12 | 28 |
| 2021 | 15 | 27 |
| 2022 | 11 | 27 |
| 2023 | 12 | 20 |
| 2024 | 12 | 35 |
| 2025 | 12 | 26 |
| 2026 | 6 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Long lived T cells for treating HIV infection4 Aug 2026US 12,698,318 B2Case Western Reserve University
- Chimeric protein comprising anti-XCR1 antibody and modified interferon alpha 216 Jun 2026US 12,655,186 B2Orionis Biosciences BV
- Fusion proteins and uses thereof28 Apr 2026US 12,611,440 B2Synklino A/S
- Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies24 Mar 2026US 12,584,138 B2ImmunityBio, Inc.
- Methods and compositions for reconstituting microglia17 Mar 2026US 12,576,110 B2Children's Medical Center Corporation
- Application of CCR5hi Innate Immune Memory Cells in Preparation of Immunotherapeutic Drug for Treating Sepsis8 Oct 2026US 2026/0306538 A1Children's Hospital of Soochow University
- Anti-pd-1 chimeric antigen receptor t cells and therapeutic uses thereof20 Aug 2026US 2026/0240908 A1Fred Hutchinson Cancer Center
- Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies20 Aug 2026US 2026/0242801 A1ImmunityBio, Inc.
- Armoured regulatory t cell13 Aug 2026US 2026/0234559 A1King's College London
- Nucleic Acids Encoding Soluble PD-1 and IL-12 and Uses Thereof13 Aug 2026US 2026/0234662 A1KaliVir Immunotherapeutics, Inc.
Most cited
By later US patents
- G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof125US 5,939,320 ANew York University · 1999
- Humanized anti-CCR2 antibodies and methods of use therefor73US 6,696,550 B2Millennium Pharmaceuticals, Inc. · 2004
- Polynucleotides encoding human G-protein chemokine receptor HDGNR1069US 6,025,154 AHuman Genome Sciences, Inc. · 2000
- Editing of CCR5 receptor gene to protect against HIV infection62US 10,745,677 B2President and Fellows of Harvard College · 2020
- Therapeutic chemokine receptor antagonists55US 6,875,738 B1The University of British Columbia of Industry Liaison Office · 2005